Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | BRD1 | O95696 | 1/20 | 0.38 |
| ▸ | TAF1 | P21675 | 1/20 | 0.38 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | HTR3A | P46098 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | RAD52 | P43351 | 1/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16440159 | 0.83 | ALDH1A1 (0.43) | ALDH1A1HTTHTR1AHTR3APOLB | |
| SCHEMBL3930015 | 0.81 | ALDH1A1 (0.33) | ALDH1A1HTTCHRM2CHRM4CHRM5 | |
| SCHEMBL14804171 | 0.80 | ALDH1A1 (0.49) | ALDH1A1HTTCHRM2CHRM4CHRM1 | |
| SCHEMBL13419433 | 0.80 | ALDH1A1 (0.53) | ALDH1A1HTTCYP1A2CYP3A4HTR1A | |
| SCHEMBL14804176 | 0.79 | ALDH1A1 (0.40) | ALDH1A1HTTCYP1A2CYP3A4HTR1A | |
| SCHEMBL1057318 | 0.78 | ADRB1 (0.50) | ALDH1A1HTTKDM4EPOLBNOTUM | |
| SCHEMBL21388470 | 0.77 | ALDH1A1 (0.46) | ALDH1A1HTTCYP1A2CYP3A4HTR1A | |
| SCHEMBL12908043 | 0.77 | ALDH1A1 (0.58) | ALDH1A1HTTCYP1A2CYP3A4HTR1A | |
| SCHEMBL28820527 | 0.77 | ALDH1A1 (0.63) | ALDH1A1HTTCYP1A2CYP3A4MAPT | |
| SCHEMBL16825130 | 0.77 | ALDH1A1 (0.57) | ALDH1A1HTTMAPTKDM4ERAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6107039-A | MIXING SAMPLE OF NUCLEIC ACID SEQUENCE TO BE ANALYZED WITH OLIGONUCLEOTIDE PROBE CONTAINING AT LEAST ONE THIOL-PROTECTED PYRIMIDINE NUCLEOTIDE, EXPOSING TO ENDONUCLEASE, AND IDENTIFYING FRAGMENTS HAVING HYBRIDIZED PROBE | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA | 2000-08-22 | — | — | US | claimed |
| US-6008334-A | MODIFIED PYRIMIDINE NUCLEOSIDES/NUCLEOTIDES WITH PROTECTED THIOL GROUP ATTACHED AT 5 POSITION OF BASE THAT IS NOT INVOLVED IN WATSON-CRICK BASE PARING; FOR USE IN CHEMICAL AND ENZYMATIC SYNTHESIS OF NUCLEIC ACIDS | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 1999-12-28 | — | — | US | claimed |
| EP-0934330-A1 | BASE-PROTECTED NUCLEOTIDE ANALOGS WITH PROTECTED THIOL GROUPS | Hanna, Michelle M. (US) | 1999-08-11 | — | — | EP | claimed |
| WO-1998003532-A9 | BASE-PROTECTED NUCLEOTIDE ANALOGS WITH PROTECTED THIOL GROUPS | — | 1998-05-28 | — | — | WO | claimed |
| WO-1998003532-A1 | BASE-PROTECTED NUCLEOTIDE ANALOGS WITH PROTECTED THIOL GROUPS | HANNA MICHELLE M (US) | 1998-01-29 | — | — | WO | claimed |
| WO-1994001445-A1 | BASE-PROTECTED NUCLEOTIDE ANALOGS WITH PROTECTED THIOL GROUPS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1994-01-20 | — | — | WO | claimed |
| US-8835125-B2 | Methods and compositions for selective labeling of different biotinylated targets within multicolor or multilabel assays | AFFYMETRIX, INC. (US) | 2014-09-16 | — | — | US | disclosed |
| US-20120226027-A1 | Methods and Compositions for Selective Labeling of Different Biotinylated Targets within Multicolor or Multilabel Assays | AFFYMETRIX, INC. (US) | 2012-09-06 | — | — | US | disclosed |
| EP-2150533-B1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ETHENYLPHENYL ALCOHOLS | LONZA AG (CH) | 2010-07-14 | — | — | EP | disclosed |
| US-20100130745-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ETHENYLPHENYL ALCOHOLS | MCGARRITY JOHN | 2010-05-27 | — | — | US | disclosed |
| EP-2150533-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ETHENYLPHENYL ALCOHOLS | LONZA AG (CH) | 2010-02-10 | — | — | EP | disclosed |
| EP-2032525-A1 | DEUTERATED AMINOGLYCIDYL COMPOUNDS | Auspex Pharmaceuticals Inc. (US) | 2009-03-11 | — | — | EP | disclosed |
| WO-2008131932-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ETHENYLPHENYL ALCOHOLS | LONZA AG (CH) | 2008-11-06 | — | — | WO | disclosed |
| EP-0934330-A1 | BASE-PROTECTED NUCLEOTIDE ANALOGS WITH PROTECTED THIOL GROUPS | Hanna, Michelle M. (US) | 1999-08-11 | — | — | EP | disclosed |
| US-5936077-A | PROTECTING EXOCYCLIC AMINO GROUPS OF NUCLEOTIDE WITH A CYCLIC DIACYL GROUP; COUPLING NUCLEOTIDE TO SOLID SUPPORT; SEQUENTIALLY LINKING NUCLEOTIDES TOGETHER; DEPROTECTING WITH STRONG, NONNUCLEOPHILIC BASE IN ORGANIC SOLVENT | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-08-10 | — | — | US | disclosed |
| US-5808035-A | OLIGOMER BIOSYNTHESIS | USHER, DAVID A. | 1998-09-15 | — | — | US | disclosed |
| WO-1998003532-A9 | BASE-PROTECTED NUCLEOTIDE ANALOGS WITH PROTECTED THIOL GROUPS | — | 1998-05-28 | — | — | WO | disclosed |
| WO-1998003532-A1 | BASE-PROTECTED NUCLEOTIDE ANALOGS WITH PROTECTED THIOL GROUPS | HANNA MICHELLE M (US) | 1998-01-29 | — | — | WO | disclosed |
| US-5631362-A | FORMING DNA AND RNA BY POLYCONDENSATION OF MONONUCLEOTIDES WITH PROTECTIVE SULFONYLALKYL DIMETHYLAMINONAPHTHALENE GROUPS FOR ALKOXY FURAN GROUPS | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-05-20 | — | — | US | disclosed |
| WO-1994001445-A1 | BASE-PROTECTED NUCLEOTIDE ANALOGS WITH PROTECTED THIOL GROUPS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1994-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130745-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ETHENYLPHENYL ALCOHOLS | ADH1A, ADH1C, ADH5 | ALDH1A1 14/4885HTT 3290/4885BRD1 456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.